American Chemical Society Division of Medicinal Chemistry

Conformationally directed drug design : peptides and nucleic acids as templates or targets : based on a symposium sponsored by the Division of Medicinal Chemistry at the 186th Meeting of the American Chemical Society, Washington, D.C., August 28-September 2, 1983 by Symposium of the American Chemical Society( Book )

8 editions published in 1984 in English and held by 369 WorldCat member libraries worldwide

Pro-drugs as novel drug delivery systems : a symposium by Takeru Higuchi( Book )

8 editions published in 1975 in English and held by 361 WorldCat member libraries worldwide

Drug metabolism concepts : a symposium cosponsored by the Division of Medicinal Chemistry and the division of Analytical Chemistry at the 172nd meeting of the American Chemical Society, San Francisco, Calif., August 31, 1976 : [Proceedings] by Donald M Jerina( Book )

12 editions published in 1977 in English and held by 352 WorldCat member libraries worldwide

Taxane anticancer agents : basic science and current status : developed from symposia sponsored by the Divisions of Chemical Health and Safety, Medicinal Chemistry, and Organic Chemistry at the 207th National Meeting of the American Chemical Society, San Diego, California, March 13-18, 1994 by American chemical society( Book )

12 editions published between 1994 and 1995 in English and held by 322 WorldCat member libraries worldwide

Presents an overview of the development of paclitaxel as an anticancer drug, including the discovery, initial development, current status, supply issues, and recent clinical developments. Discusses in detail the cellular mechanism of action and the toxicity of paclitaxel. Presents drug delivery and taxotere metabolism. Explains semisynthetic and medicinal chemistry studies. Covers approaches to the total synthesis of paclitaxel

Antihypertensive agents : a symposium sponsored by the Division of Medicinal Chemistry at the 169th meeting of the American Chemical Society, Philadelphia, Penn., April 8, 1975 by Edward L Englehardt( Book )

8 editions published in 1976 in English and held by 322 WorldCat member libraries worldwide

During the past quarter of a century, there has been a continuing trend by the clinician to use antihypertensive therapy in patients with less and less severe hypertensive disease. This has led to a need for agents that are effective in milder degrees of hypertension and substantially free from side effects that might reduce compliance of the patient with the therapeutic regimen. The four papers that comprise this volume provide a concise overview of the current status of antihypertensive agents in use or in the later stages of development in 1975. The development of new agents to permit better control of blood pressure while restoring normal hemodynamics with minimal side effects presents a continuing challenge to the medicinal chemist. Doubtless improved agents that fall into the pharmacological classes now recognized will be developed. The complexity of the interplay of neural and renal factors involved in the control of blood pressure gives hope that other points for therapeutic intervention will be found as our basic knowledge of the pathophysiology of hypertensive vascular disease increases. - from the preface

Medicinal inorganic chemistry( Book )

5 editions published in 2005 in English and held by 319 WorldCat member libraries worldwide

"This book, a compilation by experts in the field, is designed to provide an introduction to the area of medicinal inorganic chemistry and to summarize current, state-of-the-art developments in the field. Medicinal inorganic chemistry represents a key thrust area in medicine and biological inorganic chemistry. It is one of great current excitement and achievement. The field of metals in medicine represents an approximate $3 billion dollar a year industry, with successes in the area of Tc- and Gd-based imaging agents and Pt-based cancer therapeutics being major contributors to this bottom line. It has become increasingly apparent, however, that metal-based pharmaceuticals can play a prominent role in areas outside of imaging and oncology, including in those associated with the diagnosis and treatment of metabolism- and genetic disorders, cardiovascular disease, gene therapy, inflammation, reperfusion injury, stroke, diabetes, ALS, malaria, and neurological disease to name but a few. A objective of this book, therefore, is to highlight these opportunities for future advances and to foster further interactions between those working in the metal-based drug development, including imaging agents, and those engaged in the more classic pharmaceutical industries."--Publisher description

Drugs affecting the respiratory system : based on a symposium sponsored by the Division of Medicinal Chemistry, at the 175th meeting of the American Chemical Society, Anaheim, California, March 13-16, 1978( Book )

6 editions published in 1980 in English and held by 308 WorldCat member libraries worldwide

Biomedical frontiers of fluorine chemistry : developed from symposia sponsored by the Division of Fluorine Chemistry and the Division of Medicinal Chemistry by Iwao Ojima( Book )

8 editions published in 1996 in English and held by 306 WorldCat member libraries worldwide

Aminocyclitol antibiotics : based on a symposium by Kenneth L Rinehart( Book )

3 editions published in 1980 in English and held by 288 WorldCat member libraries worldwide

Diuretic agents : based on a symposium sponsored by the ACS Division of Medicinal Chemistry at the 174th meeting of the American Chemical Society, Chicago, Illinois, August 29, 1977 by American Chemical Society( Book )

5 editions published in 1978 in English and held by 276 WorldCat member libraries worldwide